share_log

九洲药业(603456.SH):上半年净利润4.75亿元 同比减少23.62%

Zhejiang Jiuzhou Pharmaceutical (603456.SH): Net income in the first half of the year was 0.475 billion yuan, a decrease of 23.62% year-on-year.

Gelonghui Finance ·  Aug 26 04:58

On August 26th, Jiuzhou Pharmaceutical (603456.SH) released its semi-annual report. During the reporting period, the company achieved revenue of 2.764 billion yuan, a decrease of 15.07% compared to the previous year; the net income attributable to the parent company was 0.475 billion yuan, a decrease of 23.62% compared to the previous year. During the reporting period, the company was awarded multiple honors, including being ranked in the top 20 CDMO enterprises in the 2024 China Medicine market, being listed in the top 100 Chinese pharmaceutical industry companies of 2023 - 2023 China CXO Enterprise TOP20, and being recognized as a leading company in the biomedicine industry in Zhejiang Province.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment